[Treatment of gastroduodenal ulcer with inhibitors of beta-adrenergic and gastric sensory receptors. Experimental and clinical study with the "Proxizin" preparation].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000818:Animals; D001566:Benzocaine / Q000627:therapeutic use*; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013276:Stomach Ulcer / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D004338:Drug Combinations; D008012:Lidocaine; D011433:Propranolol; D001566:Benzocaine
Contribuţii la tratamentul ulcerului gastroduodenal prin inhibitori ai receptorilor beta-adrenergici şi senzoriali gastrici. Studiu experimental şi clinic cu preparatul "Proxizin".